Finnish Study Links Denosumab to Jaw Necrosis in Breast Cancer
Medication-related osteonecrosis of the jaw affected 12.6% of breast cancer patients treated with denosumab for bone metastases during a Finnish registry study published on September 29, 2026, in Clinical Oral ... Read More